Unusual Machines, Inc.
For the period ended Dec 31, 2024. Filed Mar 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 27, 2025
UMAC$12.59-6.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 2024 and 2023
Balance Sheets
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| Current assets: | ||
| Cash & cash equivalents | $3,757,323 | $894,773 |
| Accounts receivable | 66,575 | – |
| Inventories | 1,335,503 | – |
| Prepaid inventory | 904,728 | – |
| Other current assets | 31,500 | 120,631 |
| Total current assets | 6,095,629 | 1,015,404 |
| Property and equipment, net | 570 | 1,254 |
| Deferred offering costs | – | 512,758 |
| Operating lease right-of-use assets | 323,514 | – |
| Other assets | 59,426 | – |
| Goodwill | 7,402,906 | – |
| Intangible assets, net | 2,225,530 | – |
| Total non-current assets | 10,011,946 | 514,012 |
| Total assets | $16,107,575 | $1,529,416 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable and accrued expenses | $668,732 | $114,497 |
| Deferred revenue | 197,117 | – |
| Operating lease liability | 67,820 | – |
| Total current liabilities | 933,669 | 114,497 |
| Long-term liabilities | ||
| Deferred tax liability | 93,793 | – |
| Operating lease liability – long term | 262,171 | – |
| Total liabilities | 1,289,633 | 114,497 |
| Commitments and contingencies (Note 15) | – | – |
| Stockholders’ equity: | ||
| Series A preferred stock - $0.01 par value, 4,250 authorized and 0 and 0 shares issued and outstanding at December 31, 2024 and 2023, respectively | – | – |
| Series B preferred stock - $0.01 par value, 10,000,000 authorized and 0 and 190 shares issued and outstanding at December 31, 2024 and 2023, respectively | – | 2 |
| Series C preferred stock - $0.01 par value, 3,000 authorized and 0 and 0 shares issued and outstanding at December 31, 2024 and 2023, respectively | – | – |
| Common stock - $0.01 par value, 500,000,000 authorized and 15,122,018 and 3,217,255 shares issued and outstanding at December 31, 2024 and 2023, respectively | 151,221 | 32,173 |
| Additional paid in capital | 50,580,235 | 5,315,790 |
| Accumulated deficit | (35,913,514) | (3,933,046) |
| Total stockholders’ equity | 14,817,942 | 1,414,919 |
| Total liabilities and stockholders’ equity | $16,107,575 | $1,529,416 |
See accompanying independent auditor’s report and notes to the financial statements.** **
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.